This course covers current FDA regulatory compliance with respect to developing medical devices. Focus will be placed on relevant aspects of FDA regulation to V&V and Risk Analysis and the FDA's supplemental guidelines. An ISO perspective is offered to compliment the FDA view.
Among the topics to be discussed are: Context of V&V and Risk Analysis within the overall quality system and regulation, V&V and Risk analysis procedures, V&V methodologies, V&V strategies, types of risk analysis, risk mitigation, and methods to determine probability and severity for Risk analysis.
This course has been pre-approved by the Regulatory Affairs Professionals Society (RAPS) as eligible for 12 credits towards a participant's RAC recertification upon full completion.
This course will be most valuable to medical device industry engineers, engineering managers, regulatory affairs professionals, scientists, and quality engineers needing an understanding of Validation and Verification (V&V) per FDA's 21 CFR Part 820.30 (f, g), ISO 13485-2003, and Risk Analysis Techniques consistent with ISO 14971-2007, as well as EN ISO 14971-2012.
Personnel involved in product development, design, manufacturing, quality assurance, or regulatory affairs that do not have an in-depth knowledge of Design V&V, Risk Analysis, and its workings, will benefit from this course. Additionally, this program can be customized and delivered on-site for more experienced personnel (including middle and upper management) to update and broaden their knowledge in these subjects.
Context for Validation, Verification, and Risk Analysis within the Medical Device Project
Context within Procedure Based Quality System
Development of Validation and Verification Plan
Use of Validation and Verification Protocols
Verification and Verification Strategies
Methodologies to Analyze Risk
Creation of Summary Risk Analysis
Upon completion of this course, attendees will have an understanding of the framework for Design V&V, Risk Analysis and recommendations to effectively meet the regulatory requirements relating to these. Emphasis will be placed not only on regulatory aspects, but on effective strategy, which is very important to avoid spending unnecessary time and money on ineffective techniques while ensuring that the requirements for medical products are met successfully.
The first day will cover the general context for V&V and Risk Analysis in relation to quality systems, standards, and procedures. The course will then focus on implementation aspects of key parts of V&V which will continue into the second day. Attendees will participate in several exercises designed to reinforce key concepts from the presentation. Participants will receive extensive course notes that can be used as reference material once the course is completed.
"The instructor had good depth and breadth of knowledge and presented it very well. A great introduction to the course material." Dan C., V & V Research Engineer, Kardium
"The course was fantastic. It was the best Medical Device Course I have attended." David H., Clinical Trials Coordinator, Cook Biotech
"The course was very informative. The course director was well informed and conveyed a wealth of experience in the practical application of course material." Alastair R., Doctor, D3 Technologies
"This course was very beneficial and went into more detail that I expected. The real life examples were great. The instructor did a nice job of keeping the class engaged and attentive. This was a useful course and I would recommend it." Jennie R., Clinical Research Associate, Ocular Therapeutics
"This course director has an extensive fund of knowledge and experience in regulatory affairs, clinical research and compliance, which he communicates very effectively to course attendees. He has enabled me and inspired me to pay greater attention to detail in the course of my clinical research activities as a multi-center trial P.I. than ever before. Thank you!" Dr. Alexander S., Colonel, US Army
"The Course Director, Byron Larson, was very engaging. His course exercises really helped implement the course material in a hands on approach." Nicole G., Biochemist, Siemens Healthcare Diagnostics
"Presentation highly organized and timed. Highly recommended!" Joseph W., Manufacturing Engineer, Covidien
"The instructor did an excellent demonstration of validation versus verification. The instructor took a myriad of questions from attendees with significantly different knowledge bases and answered them thoughtfully and with excellent real life examples." Anthony G., Validation Manager, BioMimetic
"Great course filled with so much useable information." Lynn C., QA Manager, Stemcell Technologies
"The course director showed his breadth of knowledge by providing examples and background on demand on all the topics we covered. He specifically helped me with practical guidelines for my 'task at hand'. This was a valuable class!" Richard P., Software Developer
Yes. The Design Validation, Verification, and Risk Analysis course provides a deeper, narrower, and more strategic look at the topics of Validation, Verification, and Risk Analysis as compared to the Design Control course. The Design Control course covers greater breadth and a more comprehensive overall view of Design Controls. The two courses are intended to be complimentary.
The course does discuss the relationship between relevant parts of the ISO 13485-2003 and FDA's 21 cfr part 820 regulation. After a comparison is established, the course materials follow FDA's 21 cfr part 820.30 references. Since the ISO 13485:2007 is not a free standard, it is not possible to distribute it with the course material.
The course also applies concepts consistent with ISO 14971:2007 as well as EN ISO 14971:2012. Since the ISO 14971:2007 and EN ISO 14971:2012 standards are not free, it is not possible to distribute it with the course material.
A course notebook is provided that contains the slides that are presented, publicly available reference materials from FDA and other entities, class exercises, and example documents and procedures.
No. A wide variety of medical device types are affected by the regulation, thus a broad view is presented.
To the extent that other Design Control topics touch Design, Validation, Verification, and Risk Analysis, they will be discussed. Process Validation is discussed to the extent it can be contrasted with Design Validation.
Each person attending a course will be asked to set up an Attendee Profile Account during the registration process.
Accounts are a new feature on our website. Creating an Account helps you view your order history and manage your training programs.
If you are registering for others, please set up an Account in the Attendee’s name. If you are
registering more than one person, you’ll need to set up a separate account for each Attendee.
*Valid up to 30 days prior to course date(s). Cannot be combined with other discounts or offers.
The Center for Professional Innovation and Education (CfPIE) provides technical training for Pharmaceutical, Biotech, Medical Device and Skin/Cosmetics professionals. CfPIE offers more than 350 class sessions annually across 80 course titles in multiple formats, such as classroom, on-site and certification programs.
Learn more »
Keep up to date with the latest news from CfPIE, including upcoming courses and events.
Members of participating industry organizations receive special discounts for all our training courses.
© 2001 - 2015 CfPIE, Inc. All Rights Reserved.